Bryce Point Capital LLC Takes Position in HCA Healthcare, Inc. (NYSE:HCA)

Bryce Point Capital LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,479 shares of the company’s stock, valued at approximately $444,000.

Several other large investors have also modified their holdings of HCA. Huntington National Bank increased its stake in HCA Healthcare by 1.1% in the 4th quarter. Huntington National Bank now owns 5,669 shares of the company’s stock worth $1,702,000 after purchasing an additional 62 shares in the last quarter. Kesler Norman & Wride LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $553,000. Meeder Advisory Services Inc. boosted its stake in HCA Healthcare by 1.4% in the 4th quarter. Meeder Advisory Services Inc. now owns 5,167 shares of the company’s stock worth $1,551,000 after purchasing an additional 69 shares during the period. Groupama Asset Managment lifted its holdings in shares of HCA Healthcare by 19.2% in the fourth quarter. Groupama Asset Managment now owns 47,131 shares of the company’s stock valued at $14,065,000 after purchasing an additional 7,601 shares in the last quarter. Finally, Trexquant Investment LP purchased a new position in shares of HCA Healthcare during the fourth quarter valued at $22,925,000. 62.73% of the stock is owned by institutional investors.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.30% of the stock is owned by insiders.

HCA Healthcare Trading Down 4.8 %

Shares of NYSE:HCA opened at $332.53 on Friday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The company has a market cap of $81.87 billion, a P/E ratio of 15.14, a P/E/G ratio of 1.10 and a beta of 1.68. The stock’s 50-day moving average is $327.23 and its 200-day moving average is $339.87.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the business earned $5.90 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were issued a $0.72 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 annualized dividend and a yield of 0.87%. HCA Healthcare’s dividend payout ratio is 13.11%.

Analysts Set New Price Targets

HCA has been the topic of several research analyst reports. Barclays lowered their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. Royal Bank of Canada cut their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a research report on Monday, January 27th. Bank of America dropped their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 27th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.